Skip to Main Content

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of blueberries — and get started. Meanwhile, do keep us in mind if you hear anything interesting. Have a smashing day …

People trust supermarkets much more than drug makers, according to a poll by Ipsos/MORI. To wit, 69 percent of more than 18,100 people in 23 countries who were surveyed last fall trust their groceries, but only 48 percent have faith in drug makers. Meanwhile, banks ranked highest when it comes to trusting an institution with personal data — 47 percent — but only 37 percent trust drug companies.


England’s National Health Service reached a deal with an unnamed drug maker to pay for a hepatitis C drug, but only if it works. Otherwise, the company must cover the cost, The Daily Mail reports. As it desperately attempts to save money, this is the first time the NHS has pursued such an arrangement, but intends to consider other such deals if this one works. The manufacturer was provided confidentiality, according to the paper.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Ed, there is a valid reason why supermarkets are trusted more than pharma. According to an obscure provision in trade secret law the FDA cannot disclose the name of a grocery store that is the subject of a food recall due to contamination. For example the soy nut butter made by I.M. Healthy was recently with withdrawn when the product caused four cases of kidney failure. Legally speaking we will never know the names of the stores involved.

    As for banks being more popular, it must be that none of the interviewees banked at Wells Fargo.

    • Hi Pharmvet1,

      Thnanks for the note and good point. And since the survey spanned 23 countries, yes, Wells Fargo was likely less of a factor. I imagine a survey of US consumers might yield a different result, though.

      ed at pharmalot

Comments are closed.